A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Clinical trial NCT00664183 · TERMINATED

Trial details

NCT number: NCT00664183
Sponsor: Vitreoretinal Technologies, Inc.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2008-03-01
Primary completion: 2009-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.